Literature DB >> 1775199

Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.

F Vanhoutte1, J Vereecke, E Carmeliet, N Verbeke.   

Abstract

Disopyramide, a Class Ia antiarrhythmic drug, is clinically used as a racemic mixture; R(-)disopyramide and S(+)disopyramide. The major metabolite in man is desisopropyldisopyramide: R(-)desisopropyldisopyramide and S(+)desisopropyldisopyramide. The effects of the four compounds were compared on the electrophysiological characteristics of the guinea-pig papillary muscle using the standard microelectrode technique. At an external K+ concentration of 5.4 mmol/l and a stimulation frequency of 1 Hz, S(+)disopyramide (20 mumols/l) increased action potential duration (APD) by more than 18%, while it was diminished by 6% in the presence of R(-)disopyramide. Resting membrane potential amounted to -87.1 +/- 0.5 mV (n = 14) and -85.6 +/- 1.2 mV (n = 10), respectively. Also a small but significant difference in effect on the maximal rate of depolarization was observed, R(-)disopyramide being more potent, related with a slower recovery of the maximal rate of depolarization. The enantiomers of the metabolite appeared to be three times less potent than those of the parent drug in their effect on the maximal rate of depolarization. The characteristics of the enantiomers of the metabolite correlated with those of the parent drug: also the R(-)enantiomer was more potent in decreasing the maximal rate of depolarization and caused more shortening of the action potential than the S(+)enantiomer. Time constants for onset and recovery of/from rate dependent block of the maximal rate of depolarization were dependent upon the external K+ concentration, both for the enantiomers of the parent drug and those of the metabolite. Onset slowed down while recovery accelerated when external K+ was increased. Time constants were lower for the metabolite. When stimulation interval was shortened, the effect on the maximal rate of depolarisation increased. Only for the metabolite statistical significant stereoselective differences were observed at all stimulation intervals. The effects on the action potential duration were dependent upon stimulation interval; for all enantiomers the action potential duration tended to be relatively (% of control) higher at short stimulation intervals than at large stimulation intervals. The effect on the maximal rate of depolarization was also voltage dependent, but no significant differences were observed between the enantiomers, for the parent drug as well as for the metabolite.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775199     DOI: 10.1007/bf00174750

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

Review 1.  The arrhythmogenic effects of antiarrhythmic drugs.

Authors:  I D Julian
Journal:  Eur Heart J       Date:  1988-02       Impact factor: 29.983

2.  Importance of physico-chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle.

Authors:  T J Campbell
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

3.  Displacement of disopyramide from human plasma proteins.

Authors:  L E Pedersen; J Bonde
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1985-09

4.  Lidocaine's negative inotropic and antiarrhythmic actions. Dependence on shortening of action potential duration and reduction of intracellular sodium activity.

Authors:  S S Sheu; W J Lederer
Journal:  Circ Res       Date:  1985-10       Impact factor: 17.367

5.  Comparison of electrocardiographic response and disposition of R- and S-disopyramide in the rabbit.

Authors:  J D Huang; S Oie
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-08

6.  Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.

Authors:  J E Bredesen; P Kierulf
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

7.  Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle.

Authors:  A M Grant; R J Marshall; S I Ankier
Journal:  Eur J Pharmacol       Date:  1978-06-15       Impact factor: 4.432

8.  Enhanced metabolism and diminished efficacy of disopyramide by enzyme induction?

Authors:  M L Aitio; T Vuorenmaa
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

9.  Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry.

Authors:  M J Mirro; A M Watanabe; J C Bailey
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

10.  Stereospecific effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine.

Authors:  G A Kidwell; S F Schaal; W W Muir
Journal:  J Cardiovasc Pharmacol       Date:  1987-03       Impact factor: 3.105

View more
  2 in total

1.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Stereoselective Inhibition of the hERG1 Potassium Channel.

Authors:  Liliana Sintra Grilo; Pierre-Alain Carrupt; Hugues Abriel
Journal:  Front Pharmacol       Date:  2010-11-22       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.